Infant Sleep Behaviour and Gut Microbacteria
NCT02836119 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 128
Last updated 2018-06-12
Summary
The overarching study aim is to evaluate the development of sleep behavior and gut microbiota (GMB), and their potential interaction, during the vulnerable period of the first year of life. Age-specific fecal profiles with bacterial genome sequencing will provide new insight into the functional coevolution of the GMB and host sleep behavior.
Conditions
- Gut Microbiota and Sleep in Infants
Sponsors & Collaborators
-
University Children's Hospital, Zurich
collaborator OTHER -
University of Zurich
lead OTHER
Principal Investigators
-
Salome Kurth, Dr. sc. nat. · Clinic for Pulmonology
Eligibility
- Min Age
- 2 Months
- Max Age
- 13 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Intestinal Function in Neonates With Complex Congenital Heart Disease
NCT01475357 ·Status: COMPLETED ·Phase: NA
-
Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children
NCT05609591 ·Status: COMPLETED ·Phase: NA
-
Characterization of Intestinal Microbiota in Children With Inborn Errors of Metabolism (IEM)
NCT05330039 ·Status: COMPLETED
-
First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic
NCT05052476 ·Status: COMPLETED ·Phase: NA
-
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
NCT00008736 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Cocoa-based Food in Children
NCT01358149 ·Status: COMPLETED ·Phase: NA
-
Bowel And Bladder Function in Infant Toilet Training
NCT04082689 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tolerability and Modulatory Action of the Butyrate Releaser N-(1-carbamoyl-2-phenyl-ethyl) Butyramide
NCT04491266 ·Status: COMPLETED ·Phase: NA
-
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
NCT01149538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Enteral Glutamine in Reducing Bloodstream Infections in Short Bowel Syndrome Infants
NCT01576003 ·Status: COMPLETED ·Phase: NA
-
Perioperative Tissue Penetration of Antimicrobials in Infants
NCT04299867 ·Status: COMPLETED
-
The Effect of Amoxicillin Versus Placebo on Gastrointestinal Motility in Children
NCT01530009 ·Status: COMPLETED ·Phase: NA
-
The Roles of Human Microbiome and Vitamin D in the Development of Childhood Allergic Diseases
NCT05670262 ·Status: RECRUITING
-
New Mechanisms of Obesity
NCT06768827 ·Status: RECRUITING ·Phase: NA
-
Neuro-Immune Interactions in the Gut
NCT03617640 ·Status: COMPLETED
-
Effects of Parenteral L-carnitine Supplementation in Premature Neonates
NCT00841295 ·Status: COMPLETED ·Phase: NA
-
Cobalamin Supplementation During Infancy; Effect on B-vitamin Status, Growth and Psychomotor Development
NCT00479479 ·Status: COMPLETED ·Phase: NA
-
Iodine Supplementation During Pregnancy and Neuropsychological Development
NCT01049659 ·Status: COMPLETED ·Phase: NA
-
A Collection of Case Studies in Infants With UCD to Evaluate Infant Growth and the Safety of a New Medical Food for UCD
NCT03911089 ·Status: COMPLETED ·Phase: NA
-
Lactobacillus Reuteri for the Treatment of Infantile Colic:
NCT01046617 ·Status: COMPLETED ·Phase: PHASE3
-
Neocate In Infants and Children With Complex Conditions
NCT04265729 ·Status: UNKNOWN ·Phase: NA
-
Antenatal Melatonin Supplementation for Neuroprotection in Fetal Growth Restriction
NCT05651347 ·Status: RECRUITING ·Phase: PHASE3
-
Mechanisms and Management of Infant Dysphagia
NCT02583360 ·Status: COMPLETED ·Phase: NA
-
Quality of Life (QOL), Coping and Psychological Symptoms in Children and Adolescents With Cyclic Vomiting Syndrome
NCT00728039 ·Status: COMPLETED
-
Cobalamin Supply and Metabolism in Healthy Children From Birth to the Age of 12 Months and in Their Mothers (Cbl_Neo)
NCT05315843 ·Status: COMPLETED